Taisuke Hamamoto

531 total citations
11 papers, 441 citations indexed

About

Taisuke Hamamoto is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Taisuke Hamamoto has authored 11 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Organic Chemistry, 3 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Taisuke Hamamoto's work include Inflammatory mediators and NSAID effects (3 papers), Synthetic Organic Chemistry Methods (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). Taisuke Hamamoto is often cited by papers focused on Inflammatory mediators and NSAID effects (3 papers), Synthetic Organic Chemistry Methods (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). Taisuke Hamamoto collaborates with scholars based in Japan and Switzerland. Taisuke Hamamoto's co-authors include Tetsuo Asaki, Keiichi Kuwano, Kenji Kuwabara, Yukiteru Sugiyama, Tetsuhiro Yamada, Asami Hashino, Koki Horikoshi, Akitami Ichihara, Keith Morrison and Martine Clozel and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and The Journal of Organic Chemistry.

In The Last Decade

Taisuke Hamamoto

11 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taisuke Hamamoto Japan 9 143 122 115 106 52 11 441
Roger P. Dickinson United Kingdom 15 14 0.1× 266 2.2× 215 1.9× 83 0.8× 31 0.6× 26 636
Jin Yin China 11 21 0.1× 107 0.9× 301 2.6× 43 0.4× 25 0.5× 15 520
Yoshikazu Yanagi Japan 12 53 0.4× 69 0.6× 281 2.4× 57 0.5× 16 0.3× 26 485
Osamu Asano Japan 12 28 0.2× 152 1.2× 215 1.9× 13 0.1× 23 0.4× 36 652
E Chinje United Kingdom 8 17 0.1× 52 0.4× 195 1.7× 49 0.5× 29 0.6× 11 394
Miguel-Angel Gallego France 4 20 0.1× 109 0.9× 189 1.6× 71 0.7× 23 0.4× 5 386
Judith M. Pisano United States 10 24 0.2× 184 1.5× 289 2.5× 17 0.2× 18 0.3× 16 616
Ján Kovaĺ Slovakia 17 193 1.3× 143 1.2× 325 2.8× 16 0.2× 13 0.3× 29 602
Junjie Yang China 14 32 0.2× 148 1.2× 188 1.6× 13 0.1× 18 0.3× 42 564
T. Kris Eckols United States 13 47 0.3× 47 0.4× 334 2.9× 27 0.3× 11 0.2× 18 633

Countries citing papers authored by Taisuke Hamamoto

Since Specialization
Citations

This map shows the geographic impact of Taisuke Hamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taisuke Hamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taisuke Hamamoto more than expected).

Fields of papers citing papers by Taisuke Hamamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taisuke Hamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taisuke Hamamoto. The network helps show where Taisuke Hamamoto may publish in the future.

Co-authorship network of co-authors of Taisuke Hamamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Taisuke Hamamoto. A scholar is included among the top collaborators of Taisuke Hamamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taisuke Hamamoto. Taisuke Hamamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Asaki, Tetsuo, Keiichi Kuwano, Keith Morrison, et al.. (2015). Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension. Journal of Medicinal Chemistry. 58(18). 7128–7137. 69 indexed citations
2.
Asaki, Tetsuo, et al.. (2008). Discovery of a novel class of 1,3-dioxane-2-carboxylic acid derivatives as subtype-selective peroxisome proliferator-activated receptor α (PPARα) agonists. Bioorganic & Medicinal Chemistry Letters. 18(6). 2128–2132. 9 indexed citations
3.
Asaki, Tetsuo, Taisuke Hamamoto, Yukiteru Sugiyama, Keiichi Kuwano, & Kenji Kuwabara. (2007). Structure–activity studies on diphenylpyrazine derivatives: A novel class of prostacyclin receptor agonists. Bioorganic & Medicinal Chemistry. 15(21). 6692–6704. 45 indexed citations
5.
Asaki, Tetsuo, Taisuke Hamamoto, Yukiteru Sugiyama, et al.. (2007). Structure–activity relationship study on the 6-membered heteroaromatic ring system of diphenylpyrazine-type prostacyclin receptor agonists. Bioorganic & Medicinal Chemistry Letters. 17(23). 6588–6592. 5 indexed citations
6.
Kuwano, Keiichi, Asami Hashino, Tetsuo Asaki, et al.. (2007). 2-{4-[(5,6-Diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide (NS-304), an Orally Available and Long-Acting Prostacyclin Receptor Agonist Prodrug. Journal of Pharmacology and Experimental Therapeutics. 322(3). 1181–1188. 141 indexed citations
7.
Asaki, Tetsuo, et al.. (2005). Design and synthesis of 3-substituted benzamide derivatives as Bcr-Abl kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(5). 1421–1425. 45 indexed citations
8.
Hamamoto, Taisuke, et al.. (1994). Total Synthesis and Stereochemistry of Alternaric Acid. The Journal of Organic Chemistry. 59(17). 4749–4759. 39 indexed citations
9.
Hamamoto, Taisuke, et al.. (1993). Total synthesis of alternaric acid. Tetrahedron Letters. 34(14). 2327–2330. 5 indexed citations
10.
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026